LOC402377 Activators
Forskolin by elevating cAMP levels, would not only activate PKA but also influence a multitude of cAMP-responsive elements, which in turn can modulate various proteins and their functions. Ionomycin, by increasing intracellular calcium levels, serves to activate calcium-dependent proteins and pathways. PMA, as a direct activator of PKC, would have a more pronounced and direct effect on proteins that are regulated by PKC-mediated phosphorylation.
IBMX and Sildenafil, through their actions on phosphodiesterases, would result in elevated cyclic nucleotide levels, thus broadening the scope of PKA and PKG pathway activation, respectively. U73122, Genistein, LY294002, PD98059, and Wortmannin represent inhibitors of specific enzymes within signaling pathways, each leading to a potential alteration in protein activity by modulating the flow within these pathways. ZM-447439's influence on cell cycle progression through Aurora kinase inhibition exemplifies the link between cell cycle regulation and protein activity. Nicotinamide's inhibition of sirtuins could impact protein activity by modifying acetylation status, showcasing the intricate network of post-translational modifications governing protein function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium concentration, which can activate calcium-sensitive signaling pathways affecting protein activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Direct activator of PKC, inducing phosphorylation and regulation of proteins involved in PKC-mediated signaling. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-selective inhibitor of phosphodiesterases, raises cAMP and cGMP levels, potentially enhancing PKA and PKG pathways that could regulate protein activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Tyrosine kinase inhibitor, can affect phosphorylation cascades and potentially alter protein activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibitor of PI3K, can affect the PI3K/Akt pathway, potentially altering the activity of proteins regulated by this pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, affecting the MEK/ERK pathway, which can lead to changes in protein activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor, can affect signaling pathways controlling protein activity. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
Aurora kinase inhibitor, alters cell cycle progression-related signaling, which can impact protein function. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Inhibits sirtuins, which can affect protein activity through post-translational modifications such as deacetylation. | ||||||